IFNAR2 - interferon alpha and beta receptor subunit 2 Gene

Also Known as IFN-R; IMD45; IFNABR; IFNARB; IFN-alpha-REC

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 3455

About IFNAR2

Cytogenetic location: 21q22.11 Genomic coordinates (GRCh38): 21:33,229,938-33,265,664 (from NCBI)

This gene has 14 transcripts (splice variants), 303 orthologues, 11 paralogues and is associated with 3 phenotypes. Ubiquitous expression in spleen (RPKM 13.0), appendix (RPKM 12.7) and 24 other tissues.

Summary

The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020]

IFNAR2 Products (8)

mRNA Protein Name
NM_000874.5 NP_000865.2 interferon alpha/beta receptor 2 isoform b
NM_001385055.1 NP_001371984.1 interferon alpha/beta receptor 2 isoform e
NM_001385054.1 NP_001371983.1 interferon alpha/beta receptor 2 isoform d
NM_001289128.2 NP_001276057.1 interferon alpha/beta receptor 2 isoform c
NM_207584.3 NP_997467.1 interferon alpha/beta receptor 2 isoform b
NM_207585.3 NP_997468.1 interferon alpha/beta receptor 2 isoform a
NM_001289125.3 NP_001276054.1 interferon alpha/beta receptor 2 isoform a
NM_001289126.2 NP_001276055.1 interferon alpha/beta receptor 2 isoform c
Molecular Function GO Annotation Evidence References Source
enables cytokine binding IPI
IPI: Inferred from physical interaction
8798579 GOA
enables protein binding IPI
IPI: Inferred from physical interaction
7665574 GOA
enables protein kinase binding IPI
IPI: Inferred from physical interaction
7759950 GOA
enables type I interferon binding IPI
IPI: Inferred from physical interaction
7759950 GOA
enables type I interferon receptor activity IDA
IDA: Inferred from direct assay
7665574 GOA
Biological Process GO Annotation Evidence References Source
involved in cell surface receptor signaling pathway via JAK-STAT IDA
IDA: Inferred from direct assay
7759950 GOA
involved in cellular response to interferon-beta IDA
IDA: Inferred from direct assay
7759950 GOA
involved in defense response to virus IMP
IMP: Inferred from mutant phenotype
26424569 GOA
involved in response to interferon-alpha IDA
IDA: Inferred from direct assay
7759950 GOA
involved in response to interferon-alpha IMP
IMP: Inferred from mutant phenotype
26424569 GOA
involved in response to interferon-beta IDA
IDA: Inferred from direct assay
7759950 GOA
involved in response to interferon-beta IMP
IMP: Inferred from mutant phenotype
26424569 GOA
involved in type I interferon-mediated signaling pathway IDA
IDA: Inferred from direct assay
7665574 GOA
involved in type I interferon-mediated signaling pathway IMP
IMP: Inferred from mutant phenotype
26424569 GOA
Cellular Component GO Annotation Evidence References Source
located in extracellular space IDA
IDA: Inferred from direct assay
7759950 GOA
located in plasma membrane IDA
IDA: Inferred from direct assay
7759950 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

IFNAR2 Protein Structure

Tissue_fac

Tissue_fac: Tissue factor (12 - 118)

Interfer-bind

Interfer-bind: Interferon-alpha/beta receptor, fibronectin type III (133 - 229)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 515 a.a.
Protein Preferred Names Protein Names

interferon alpha/beta receptor 2

  • IFN-R-2

  • IFN-alpha/beta receptor 2

  • IFNalpha/beta receptor subunit 2

  • human interferon alpha/beta receptor

  • interferon (alpha, beta and omega) receptor 2

  • interferon alpha binding protein

  • interferon receptor

  • interferon-alpha/beta receptor beta chain

  • type I interferon receptor 2

IFNAR2 Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method References
Intra
IFNAR2 P48551 STAT1 Homo sapiens P42224 9121453
Intra
IFNAR2 P48551 JAK1 Homo sapiens P23458 16710296
Intra
IFNAR2 P48551 JAK1 Homo sapiens P23458 16710296
Intra
IFNAR2 P48551 STAT2 Homo sapiens P52630 9121453
Intra
IFNAR2 P48551 STAT2 Homo sapiens P52630 17923090
Intra
IFNAR2 P48551 STAT2 Homo sapiens P52630 17923090
Intra
IFNAR2 P48551 RACK1 Homo sapiens P63244
Y2H
11046044
Intra
IFNAR2 P48551 RACK1 Homo sapiens P63244 11046044
Intra
IFNAR2 P48551 USP18 Homo sapiens Q9UMW8 16710296
Intra
IFNAR2 P48551 IFNA2 Homo sapiens P01563 21854986
Intra
IFNAR2 P48551 IRF9 Homo sapiens Q00978 17923090
Intra
IFNAR2 P48551 IRF9 Homo sapiens Q00978 17923090
Intra
IFNAR2 P48551 PDLIM1 Homo sapiens O00151 33961781
Intra
IFNAR2 P48551 CREBBP Homo sapiens Q92793 17923090
Intra
IFNAR2 P48551 CREBBP Homo sapiens Q92793 17923090
Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant IFNAR2 Proteins

Cat. No. Product Name Accession Purity
HY-P72613 IFN-alpha/beta R2 Protein, Human (HEK293, His) P48551-1 (I27-K243) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P74860 IFN-alpha/beta R2 Protein, Human (HEK293, hFc) P48551-1 (I27-K243) ≥ 90%, as determined by reducing SDS-PAGE.
HY-P74861 IFN-alpha/beta R2 Protein, Human (Biotinylated, HEK293, His) P48551-1 (I27-K243) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P74862A IFN-alpha/beta R2 Protein, Human (HEK293, His, solution) P48551-1 (I27-K243) ≥ 95%, as determined by reducing SDS-PAGE.

IFNAR2 Antibodies

Cat. No. Product Name Application Reactivity
HY-P811166 IFNAR2 Antibody WB, IHC-P Human, Mouse, Rat
HY-P89824 IFNAR2 Antibody (YA9168) WB, ICC/IF, IF-Tissue, IP, ELISA human

Related Diseases

Diseases Alias
Multiple Sclerosis
  • MS

  • Multiple Sclerosis, Susceptibility To

  • Disseminated Sclerosis

  • Multiple Sclerosis, Disease Progression, Modifier Of

  • Insular Sclerosis

  • Multiple Sclerosis Modifier Of Disease Progression

  • Multiple Sclerosis, Susceptibility To 1

  • Multiple Sclerosis, Susceptibility To, 1

  • Multiple Sclerosis 1

  • Generalized Multiple Sclerosis

  • Multiple Sclerosis Variant

  • Multiple Sclerosis Susceptibility To

  • Cerebrospinal Sclerosis

  • Generalised Multiple Sclerosis

  • Ms - [Multiple Sclerosis]

  • Disseminated Cerebrospinal Sclerosis

  • Disseminated Multiple Sclerosis

  • Disseminated Nervous System Myelosclerosis

  • Multiple Cerebrospinal Sclerosis

  • Multiple Combined Sclerosis

  • Multiple Sclerosis Generalised

  • Disseminated Brain Sclerosis

  • Disseminated Spinal Sclerosis

  • Insular Brain Sclerosis

  • Miliary Brain Sclerosis

  • Multiple Combined Sclerosis Of Spinal Cord

  • Multiple Ascending Sclerosis

  • Multiple Brain Sclerosis

  • Multiple Sclerosis Of Brain Stem

  • Multiple Sclerosis Of The Brain Stem

  • Multiple Sclerosis Of Cord

  • Sclérose En Plaques

  • Plaque Sclerosis

  • Multiple Sclerosis Of The Spinal Cord

Hepatitis C
  • Chronic Hepatitis C

  • Hepatitis C Infection

  • Hepatitis Nona Nonb

  • Nanbh

  • Viral Hepatitis C

  • Hepatitis C Chronic

  • Hepatitis C, Chronic

  • Chronic Type C Viral Hepatitis

  • Chronic Hcv - [Hepatitis C Virus] Infection

  • Hepatitis C Nos

  • Hepatitis C Infection Nos

  • Hepatitis C-Related Cirrhosis

  • Type C Viral Hepatitis

  • Hep C Nos

Multisystem Inflammatory Syndrome In Children
  • Mis-C

  • Multisystem Inflammatory Disorder In Children And Adolescents

  • Paediatric Inflammatory Multisystemic Syndrome

  • Mic

Immunodeficiency 28
  • IMD28

  • Ifngr2 Deficiency

  • Immunodeficiency 28, Mycobacteriosis, Autosomal Recessive

  • Immunodeficiency 28, Mycobacteriosis

  • Mendelian Susceptibility To Mycobacterial Diseases Due To Complete Ifngammar2 Deficiency

  • Mendelian Susceptibility To Mycobacterial Diseases Due To Complete Interferon Gamma Receptor 2 Deficiency

  • Msmd Due To Complete Ifngammar2 Deficiency

  • Msmd Due To Complete Interferon Gamma Receptor 2 Deficiency

  • Autosomal Recessive Mendelian Susceptibility To Mycobacterial Diseases Due To Partial Ifngammar2 Deficiency

  • Autosomal Recessive Msmd Due To Partial Ifngammar2 Deficiency

  • Autosomal Recessive Msmd Due To Partial Interferon Gamma Receptor 2 Deficiency

  • Autosomal Recessive Mendelian Susceptibility To Mycobacterial Diseases Due To Partial Interferon Gamma Receptor 2 Deficiency

  • Immunodeficiency, Type 28, Mycobacteriosis

Torch Syndrome
Amyotrophic Lateral Sclerosis 1
  • Amyotrophic Lateral Sclerosis

  • ALS

  • Lou Gehrig Disease

  • Amyotrophic Lateral Sclerosis Type 1

  • Charcot Disease

  • ALS1

  • Amyotrophic Lateral Sclerosis, Susceptibility To

  • Fals

  • Lou Gehrig'S Disease

  • Mnd

  • Motor Neuron Disease

  • Familial Amyotrophic Lateral Sclerosis

  • Amyotrophic Lateral Sclerosis 1, Familial

  • Amyotrophic Lateral Sclerosis 1, Autosomal Dominant

  • Motor Neuron Disease, Bulbar

  • Motor Neurone Disease

  • Amyotrophic Lateral Sclerosis With Dementia

  • Dementia With Amyotrophic Lateral Sclerosis

  • Motor Neuron Disease, Amyotrophic Lateral Sclerosis

  • Sclerosis, Lateral, Amyotrophic

  • Sclerosis, Lateral, Amyotrophic, Type 1

  • Amyotrophic Sclerosis

  • Als - [Amyotrophic Lateral Sclerosis]

  • Wasting Palsy

  • Amyotrophic Paralysis

  • Amyotrophy Lateral Sclerosis

  • Wasting Paralysis

  • Spinal Progressive Amyotrophy

  • Progressive Atrophic Paralysis

Immunodeficiency 45
  • IMD45

Rubella
  • German Measles

  • Three Day Measles

  • Rubella Nos

Immunodeficiency 44
  • IMD44

Viral Infectious Disease
  • Arbovirus Infections

  • Viral Disease

  • Virus Infection

  • Virus Diseases

  • Viral Infection

  • Viral Infections

  • Virus Infections

Herpangina
  • Vesicular Pharyngitis

Immunodeficiency 39
  • IMD39

  • Immunodeficiency, Type 39

Aicardi-Goutieres Syndrome
  • Aicardi Goutieres Syndrome

  • Cree Encephalitis

  • Encephalopathy With Basal Ganglia Calcification

  • Aicardi-Goutières Syndrome

  • Ags

  • Encephalopathy With Intracranial Calcification And Chronic Lymphocytosis Of Cerebrospinal Fluid

  • Pseudotoxoplasmosis Syndrome

  • Encephalopathy, Familial Infantile, With Calcification Of Basal Ganglia And Chronic Cerebrospinal Fluid Lymphocytosis

  • Familial Infantile Encephalopathy With Intracranial Calcification And Chronic Cerebrospinal Fluid Lymphocytosis

  • Aicardi-Goutieres Syndrome 1

Mumps
  • Parotitis Due To Mumps Virus

  • Mumps Nos

  • Epidemic Parotitis

  • Infectious Parotitis

West Nile Encephalitis
  • West-Nile Encephalitis

  • West Nile Fever

  • West Nile Fever Encephalitis

  • West Nile Fever With Encephalitis

  • West-Nile Fever

  • Encephalitis, West Nile Fever

Hepatitis B
  • Chronic Hepatitis B

  • Hepatitis B Infection

  • Serum Hepatitis

  • HBV

  • Hepatitis B Chronic

  • Hbv, Susceptibility To

  • Hepatitis B, Chronic

  • Chronic Hepatitis B Without Delta Agent

  • Chronic Hbv - [Hepatitis B Virus] Infection

  • Hepatitis B Nos

  • Chronic Type B Viral Hepatitis

  • Hep B Nos

Primary Immunodeficiency With Post-Measles-Mumps-Rubella Vaccine Viral Infection
  • Primary Immunodeficiency With Post-Mmr Vaccine Viral Infection

Measles
  • Rubeola

  • Morbilli

  • Measles Nos

  • Koplik Spots

Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Orthologs Information

Species Symbol Source ID
Bos taurus IFNAR2 VGNC VGNC:30055
Rattus norvegicus IFNAR2 RGD RGD:1583177
Macaca mulatta IFNAR2 VGNC VGNC:81330
Felis catus IFNAR2 VGNC VGNC:103734
Mus musculus IFNAR2 MGD MGI:1098243
Others IFNAR2 NCBI